These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 9547553)
1. Distribution of COX-1 and COX-2 in normal and inflamed tissues. Seibert K; Zhang Y; Leahy K; Hauser S; Masferrer J; Isakson P Adv Exp Med Biol; 1997; 400A():167-70. PubMed ID: 9547553 [TBL] [Abstract][Full Text] [Related]
3. Dual acting anti-inflammatory drugs: a reappraisal. Bertolini A; Ottani A; Sandrini M Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348 [TBL] [Abstract][Full Text] [Related]
4. Role of inducible cyclooxygenase (COX-2) in inflammation. Seibert K; Masferrer JL Receptor; 1994; 4(1):17-23. PubMed ID: 8038702 [TBL] [Abstract][Full Text] [Related]
5. Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene. Baek SJ; Wilson LC; Lee CH; Eling TE J Pharmacol Exp Ther; 2002 Jun; 301(3):1126-31. PubMed ID: 12023546 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Seibert K; Zhang Y; Leahy K; Hauser S; Masferrer J; Perkins W; Lee L; Isakson P Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12013-7. PubMed ID: 7991575 [TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2: a therapeutic target. Turini ME; DuBois RN Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462 [TBL] [Abstract][Full Text] [Related]
8. Expression and selective inhibition of constitutive and inducible forms of cyclooxygenase. Seibert K; Masferrer J; Zhang Y; Leahy K; Hauser S; Gierse J; Koboldt C; Anderson G; Bremer M; Gregory S Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():125-7. PubMed ID: 7794421 [No Abstract] [Full Text] [Related]
9. Cyclooxygenase-2 inhibitors: a new class of anti-inflammatory agents that spare the gastrointestinal tract. Masferrer JL; Isakson PC; Seibert K Gastroenterol Clin North Am; 1996 Jun; 25(2):363-72. PubMed ID: 9229578 [TBL] [Abstract][Full Text] [Related]
10. Limited anti-inflammatory efficacy of cyclo-oxygenase-2 inhibition in carrageenan-airpouch inflammation. Wallace JL; Chapman K; McKnight W Br J Pharmacol; 1999 Mar; 126(5):1200-4. PubMed ID: 10205009 [TBL] [Abstract][Full Text] [Related]
11. Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-induced intestinal damage. Tanaka A; Hase S; Miyazawa T; Takeuchi K J Pharmacol Exp Ther; 2002 Mar; 300(3):754-61. PubMed ID: 11861778 [TBL] [Abstract][Full Text] [Related]
12. [New NSAIDS: COX-1, COX-2, what about them?]. Peretz A Rev Med Brux; 1998 Sep; 19(4):A399-402. PubMed ID: 9805982 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture. Bishop-Bailey D; Larkin SW; Warner TD; Chen G; Mitchell JA Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896 [TBL] [Abstract][Full Text] [Related]
15. Systematic pharmacological approach to the characterization of NSAIDs. Lora M; Denault JB; Leduc R; de Brum-Fernandes AJ Prostaglandins Leukot Essent Fatty Acids; 1998 Jul; 59(1):55-62. PubMed ID: 9758208 [TBL] [Abstract][Full Text] [Related]
16. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Kurumbail RG; Stevens AM; Gierse JK; McDonald JJ; Stegeman RA; Pak JY; Gildehaus D; Miyashiro JM; Penning TD; Seibert K; Isakson PC; Stallings WC Nature; 1996 Dec 19-26; 384(6610):644-8. PubMed ID: 8967954 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Michaluart P; Masferrer JL; Carothers AM; Subbaramaiah K; Zweifel BS; Koboldt C; Mestre JR; Grunberger D; Sacks PG; Tanabe T; Dannenberg AJ Cancer Res; 1999 May; 59(10):2347-52. PubMed ID: 10344742 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway. Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467 [TBL] [Abstract][Full Text] [Related]
19. Nimesulide and indomethacin induce apoptosis in head and neck cancer cells. Pelzmann M; Thurnher D; Gedlicka C; Martinek H; Knerer B J Oral Pathol Med; 2004 Nov; 33(10):607-13. PubMed ID: 15482327 [TBL] [Abstract][Full Text] [Related]
20. Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications. Pairet M; Engelhardt G Fundam Clin Pharmacol; 1996; 10(1):1-17. PubMed ID: 8900495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]